Thu.Sep 19, 2024

article thumbnail

Long-overlooked scientist shares Lasker Award with other GLP-1 researchers

STAT

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease , addiction , and even Alzheimer’s. Now, three scientists who played key roles in their invention have won a prestigious Lasker Award for biomedical research.  Announced on Thursday in New York, the Lasker-DeBakey Clinical Medical Research Award will be shared by Svetlana Mojsov and Joel Habener , who identified and characterized the GLP-1 hormone in the 1980s whil

article thumbnail

At J&J, oncology R&D meets commercial strategy in a quest for new standards of care

PharmaVoice

The disparate teams of research and commercial at J&J work closely together from the get-go.

186
186
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: A failing health care system caused my husband’s death

STAT

On Tuesday, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the Agency for Healthcare Research and Quality took an important step: They launched the Core Elements of Hospital Diagnostic Excellence , a new project to help reduce the number of Americans who die or are permanently disabled each year by diagnostic error.

Hospitals 344
article thumbnail

Can the Fed’s rate cut change biotech’s ‘new normal’?

BioPharma Dive

Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.

124
124
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Ginkgo Bioworks bets on protein AI model, and data generation to turn flailing company around

STAT

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find customers. The biotech this week announced a new artificial intelligence model for use in biological research, as well as a data service academic researchers and companies can use to develop their own models. The announcement comes as a growing number of biotechs, big tech companies, and academics apply neural networks and machine learning to biology, promising that the same ba

354
354
article thumbnail

Protest action hoped to spotlight pharmacy plight

The Pharmacist

National Pharmacy Association (NPA) members across the UK have participated in a second day of action today by wearing black, displaying posters and raising awareness of the impact of funding cuts on the sector. It comes as the NPA has announced plans to escalate its action and ballot its members on 'working to rule'. Gordons […] The post Protest action hoped to spotlight pharmacy plight appeared first on The Pharmacist.

109
109

More Trending

article thumbnail

Top three trends in precision medicine

Pharmaceutical Technology

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual differences in genes, environments, and lifestyles to drive better outcomes through medicine.

105
105
article thumbnail

STAT+: FDA designates devices for heart surgery, smart knee implant as ‘breakthroughs’

STAT

Check out STAT’s exclusive breakthrough devices tracker.  The latest medical devices to receive breakthrough status from the Food and Drug Administration range across conditions, with several treating cardio and neurovascular conditions.  The FDA’s breakthrough devices program is designed to speed the path to market for novel, potentially lifesaving products.

342
342
article thumbnail

Negotiator 'interested' to hear outcome of NPA ballot

The Pharmacist

Community Pharmacy England (CPE) has suggested that the outcome of the National Pharmacy Association (NPA)'s ballot could inform considerations around its own negotiating tactics and positioning. Pharmacy sector leaders have today joined the NPA to deliver a petition to Downing Street and to voice concerns about pharmacy funding, following the membership organisation's announcement that it […] The post Negotiator 'interested' to hear outcome of NPA ballot appeared first on The Ph

article thumbnail

STAT+: Corbus sees Novo’s controversial obesity approach as a ticket to a blockbuster

STAT

NEW YORK — Nearly two decades ago, European regulators pulled an obesity drug called rimonabant off the market due to concerns it was tied to suicidal ideation. Now, a small handful of companies are developing drugs that use a similar approach to the discarded treatment, which involves inhibiting type 1 cannabinoid receptors, or CB1 receptors.

334
334
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Atopic Dermatitis: A hotspot for innovation and investment opportunities, says GlobalData

Express Pharma

Atopic dermatitis (AD) is emerging as a dynamic field ripe with innovation and investment opportunities. With the market projected to reach $16.7 billion by 2030 across the seven major markets (7MM*), driven by rising prevalence and advancements in treatment, pharmaceutical companies are increasingly focusing on novel therapies. This sector promises substantial growth as new treatments address unmet needs and reshape patient care, says GlobalData.

article thumbnail

STAT+: Lawmakers urge U.S. Patent Office and drug makers to correct patent mistakes

STAT

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling mistakes in disclosing patent terms, because the errors can be exploited in ways that thwart competition and, ultimately, raise the cost of medicines. The problem cited by the lawmakers concerns the way that administrative delays are handled at the PTO.

article thumbnail

23andMe’s independent board directors resign

BioPharma Dive

In a letter to CEO Anne Wojcicki, the directors said they’d resign “rather than have a protracted and distracting difference of view with you” about the company’s future.

98
article thumbnail

Talkspace offers therapy via Amazon, and 23andMe board members resign

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Talkspace offers therapy through Amazon now As virtual mental health company Talkspace aims to grow its business, it’s added a very large entry point to the top of its funnel.

Diabetes 283
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Cabinet approves ‘Bio-RIDE’ scheme to support R&D in Biotechnology

Express Pharma

The Union Cabinet, chaired by Prime Minister Narendra Modi, approved the continuation of the two umbrella schemes of the Department of Biotechnology (DBT), merged as one scheme – ‘Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE)’ with a new component namely Biomanufacturing and Biofoundry. The scheme has three broad components: Biotechnology Research and Development (R&D); Industrial & Entrepreneurship Development (I&ED) Biomanufacturing and Biofoun

105
105
article thumbnail

Opinion: Medicaid must prepare to cover twice-yearly HIV prevention injection

STAT

In June, a clinical trial showed that a twice-yearly injection was just as effective at preventing HIV as the daily oral medication. The trial  was so successful  that the Data Monitoring Committee instructed researchers to halt the study and immediately offer the injection to all study participants.  This is just the most recent development in longer-acting HIV medications, which have become a transformative force in the journey toward ending the HIV/AIDS crisis.

290
290
article thumbnail

Roche’s Xofluza reduces flu transmission in Phase 3 study

BioPharma Dive

According to the company, the results are the first time an antiviral drug has reduced transmission of a respiratory virus in a global Phase 3 trial.

103
103
article thumbnail

STAT+: FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents

STAT

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration. Specifically, a “large number of torn pieces” of documents that should have been kept to verify manufacturing and testing practices were found in the trucks, as well as in a scrap bag at a site run by Granules in Telangana,

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Supply chain resilience in pharma: Delivering consistency amidst global events

pharmaphorum

Explore how the pharmaceutical industry is ensuring supply chain resilience to maintain consistency despite global events. Learn more about strategies and practices implemented to address challenges and ensure reliable delivery of pharmaceutical products.

96
article thumbnail

Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

STAT

Are generalist investors good or bad for biotech? How did Elaine and Adam’s trip to New York go? And how long has George Church owned that brown corduroy blazer? We cover all that and more on the latest episode of “The Readout Loud.” Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve’s long-awaited decision to lower interest rates means for biotech stocks and startups.

276
276
article thumbnail

analytica Anacon India, India Lab Expo, and Pharma Pro&Pack Expo to host the largest-ever edition in Hyderabad

Express Pharma

Following a successful edition in 2023, analytica Anacon India and India Lab Expo along with Pharma Pro&Pack Expo are set to make their mark in Hyderabad, the pharma hub of India, from September 26-28. This year’s event will be the largest edition to date, featuring over 500+ technology suppliers from 14+ countries. The triad event aims to create a transformative experience for the pharmaceutical, analytical, biotechnology, and R&D sectors.

Packaging 102
article thumbnail

STAT+: Corbus shares will soar or dive soon. Here’s why

STAT

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I’ve been in New York City all week attending the Cantor Global Healthcare Conference and meeting with investor sources. Big thanks to Cantor hosts Josh Schimmer and Eric Schmidt for the invite.

270
270
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Fermenta Biotech’s Dahej facility gains EU GMP certification

Express Pharma

Fermenta Biotech’s Active Pharmaceutical Ingredient (API) manufacturing facility situated in Dahej, Gujarat, has received a certificate of GMP compliance from the Competent Authority of Germany, following a European Union Good Manufacturing Practice (EU GMP) inspection that was conducted in March 2024. This approval reflects that the company’s quality assurance complies with the guidelines of Good Manufacturing Practices.

102
102
article thumbnail

STAT+: Senate panel votes to hold Steward Health Care CEO in contempt

STAT

A Senate committee on Thursday approved referring Steward Health Care chief executive Ralph de la Torre for civil and criminal charges over his refusal to testify about the hospital chain’s financial crisis. The Senate Health, Education, Labor, and Pensions Committee voted 20 to zero, with only Kentucky Senator Rand Paul abstaining, on both resolutions to hold de la Torre in contempt of Congress after  he skipped appearing at a hearing last week  despite being subpoenaed.

Hospitals 263
article thumbnail

Piramal Pharma’s GHG commitment validated and approved by SBTi

Express Pharma

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets. Piramal has committed to reducing absolute scope 1 and 2 GHG emissions by 42 per cent by FY2030 from an FY2022 base year. It has also committed to reducing absolute scope 3 GHG emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution,

article thumbnail

STAT+: Pharmalittle: We’re reading about a rare-disease drug bill, compounded Wegovy, and more

STAT

Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a beautiful day as well, despite forecasts suggesting a cloud or two will later hover about. Right now, the skies are tranquil, birds are chirping, and the official mascots are hunting for snacks on the Pharmalot campus. This calls for celebration with a cup of stimulation, and we are reaching for maple bourbon, a reliable stand-by.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Neuralink gets breakthrough tag for sight-restoring implant

pharmaphorum

Neuralink gets FDA breakthrough status for an implantable chip called Blindsight that promises to restore eyesight to the blind

110
110
article thumbnail

The Fed cut rates and biotech stocks… didn’t do much

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Some news from Washington from late yesterday: Lawmakers advanced legislation that would extend a program to aid the development of drugs for rare diseases in children.

article thumbnail

Laurus Labs inaugurates new R&D facility at IKP Knowledge Park

Express Pharma

Laurus Labs an R&D-driven pharmaceutical and biotech company in India has inaugurated a new R&D center at IKP Knowledge Park, Plot No DS15, Kolthur Shamirpet Medchal, Telangana. The new facility was inaugurated by Duddilla Sridhar Babu Garu, Minister of Information Technology, Electronics and Communications, Industries and Commerce, and Legislative Affairs – Government of Telangana along with Dr Satyanarayana Chava, Founder and CEO Laurus Labs along with other senior management team m

article thumbnail

Respiratory biotech Upstream joins Nasdaq IPO surge

pharmaphorum

Upstream Bio has become the latest biotech to chance its arm with a public listing in the US, seeking funds for its rival to respiratory drug Tezspire.

102
102
article thumbnail

Pharmacy Technicians: Working Inpatient vs. Outpatient?

The Script

Pharmacy technicians have their choice when it comes to working in inpatient or outpatient settings. Rx relief discusses the differences.